Return to Listing

1 result(s) for Ipilimumab

PI Name Protocol # Title
Julie Graff IRB00005254 A Phase II Study of CTLA Blockade by Ipilimumab plus Androgen Suppression Therapy in Patients with an Incomplete Response to AST Alone for Metastatic Prostate Cancer

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080